🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine the recommended dose and schedule...
Status
Terminated
Location
Local Institution - 0033
Start Date
2024-02-27
Trial ID
NCT06163898
Treatments Being Tested
Multiple myeloma (MM) is the second most common hematologic malignancy with...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-10-02
Trial ID
NCT06050512
Treatments Being Tested
This is a single-center, open-label study to be conducted in healthy adult ...
Status
Completed
Location
Covance Clinical Research Unit Inc
Start Date
2020-10-15
Trial ID
NCT04560738
Treatments Being Tested
This phase Ib trial tests the safety, side effects, and best dose of CC-924...
Status
Active Not Recruiting
Location
Ohio State University Comprehensive Cancer Center
Start Date
2023-12-21
Trial ID
NCT05981209
This phase I trial studies the safety, side effects, best dose and effectiv...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2024-04-09
Trial ID
NCT06048250
The purpose of the study is to compare Mezigdomide (CC-92480/BMS-986348) wi...
Status
Active Not Recruiting
Location
Local Institution - 0046
Start Date
2023-01-10
Trial ID
NCT05552976
Treatments Being Tested
This study will independently assess the efficacy and safety of 11 combinat...
Status
Recruiting
Location
Banner MD Anderson Cancer Center
Start Date
2015-10
Trial ID
NCT02343042
The purpose of this study is to evaluate the safety and preliminary efficac...
Status
Active Not Recruiting
Location
Local Institution - 119
Start Date
2019-09-30
Trial ID
NCT03989414
Treatments Being Tested
This is a Phase 1 study that will be conducted in 2 parts. Participants may...
Status
Completed
Location
PPD Phase 1 Clinic
Start Date
2021-01-19
Trial ID
NCT04839809
This phase II trial studies how well mezigdomide/carfilzomib/dexamethasone ...
Status
Recruiting
Location
Roswell Park Cancer Institute
Start Date
2025-05-01
Trial ID
NCT06627751